Acta Cancerológica     2003; 32 (1): 22-27

 

ONCOPROTEÍNAS VIRALES, APOPTOSIS Y PROLIFERACIÓN CELULAR EN LA
CARCINOGÉNESIS DE PULMÓN: E6-E7, P53,
BCL-2, BAX y PCNA

 

BIBLIOGRAFÍA

  1. Da J., Chen L., Hu Y. 1996. Human papillomavirus infection and p53 gene mutation in primary lung cancer. Chung Hua Chung Liu Tsa Chih 18(1): 27-29.

  2. Field J. 1992. Oncogenes and tumoursuppressor genes in squamous cell carcinoma of the head and neck. Oral Oncol Eur J Cancer 28B(1): 67 - 76.

  3. Fontanini G., Vignati S., Bigini D., Mussi A., Lucchi M., Chine S., Angeletti C., Bepilacqua G. 1996. Recurrence and death in non-small cell lung carcinomas: a prognostic model using pathological parameters, microvessed count, and gene protein products, Clin Cancer Res 2(6): 1067 -1075.

  4. Fontanini G., Boldrini L., Vignati S., Chiné S., Basolo F., Silvestri V., Lucchi M., Mussi A., Angeletti C.m, Bevilacqua G. 1998. Bcl-2 and p53 regulate vascular endothelial growth factor (VEGF)-mediated angiogenesis in non-small cell lung carcinoma Eur J Cancer 34(5): 718 - 722.

  5. Gissmann L., WoInik L., Ikenberg H., KoIdovsky U., Schnurch H., zur Hausen H. 1983. Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal paplliomas and in some cervical cancers. Proc Natl Acad Sci USA 80: 560 -563.

  6. Guillou L, Salí R, Chaubert P, Monnier P, Cuttat JF, Costa J. 1991. Squamous cell carcinoma of the lung in a non-smoking, nonirradiated patient with juvenile laryngotracheal papillomatosis. Evidence of human papillomavirus- 11 DNA in both carcinoma and papillomas. Am J Surg Pathol 15(9): 891 - 898.

  7. Gutierrez M., Cherney B., Hussain A., Mostowski H., Tosato G., Magrath I., Bhatia K. 1999. Bax is frequently compromised in Burkitt's lymhomas with irreversible resistance to fas-induced apoptosis. J Cancer Reser 59: 696 -703.

  8. Harima Y., Oka A., Nagata K., Harima K., Tanaka Y., Shikata N. 1998. Bax and bcl-2 expression predict response to radiotherapy in human cervical cancer. Gan to Kagaku Ryoho 25(9): 1273 -1277.

  9. Harris C., Hollstein M. 1993. Clinical implications of the p53 tumor suppressor gene. New Engl J Med 329: 1318 - 1327.

  10. Hirayasu T., IwamasaT., KarnadaY, Koyanagi Y., Usuda H., Genka K. 1996. Human papillomavirus DNA in squamous cell carcinoma of the lung. J Clin Pathol 49(10): 810 - 817.

  11. Iggo R., Gatter K., Bartek J., Lane D., Harris A. 1990. Increased expression of mutant forms of p53 oncogene in primary lung cancer 335: 635 - 675.

  12. Kawasaki M., Nakanishi Y, Kuwano K., Takayarna K., Kiyohara C., Hara N. 1998. Immunohistochemically detected p53 and P-glycoprotein predict the response to chernotherapy in lung cancer. Eur J Cancer 34 (9): 1352 -1357.

  13. Kellokoski J., Syrjanen S., Yliskoski M., Syranen K. 1992. Dot blot hybridization in detection of human papillomavirus (HPV) infections in the oral cavity of women with genital HPV infections. Oral Microb Immunol 7: 19 - 23.

  14. Liloglou T., Ross H., Prime W., Donnelly R., Spandidos D,, Gosney J., Field J. 1997. p53 gene aberrations in non-small-cell lung carcinomas from a smoking population. Br J Cancer 75(8): 1119 - 1124.

  15. McKaig R., Baric R., Olshan A. 1997. Human papillomavirus and head and neck cancer: epidemiology and molecular biology. Head&Neck 20: 250-265.

  16. Mei L., Lezhen C., Po Z., Zheng G., Yali L., Nan L. 1998. Study on the metastatic mechanisms of human giant-cell lung carcinoma comparison between the strains C and D. Asian Pac J Allergy Immunol 16(4): 167 - 176.

  17. Ohno T, Nakano T, Niibe Y, Tsujii H., Oka K. 1998. Bax protein expression correlates with radiation-induced apoptosis in radiation therapy for cervical carcinoma. Cancer 83(1): 103 - 110.

  18. Punwaney R., Brandwein M., Zhang D., Urken M., Cheng R., Park Ch., Li H. 1998. Human papillomavirs may be common within nasopharingeal carcinoma of caucasian americans: investigation of EBV and HPV in eastern and western nasopharyngeal carcinoma using ligation - dependent PCR. Head & Neck 21: 21 - 29.

  19. Rady P, Schnadig V, Weiss R, Hughes T, Tyring S. 1998. Malignant transformation of recurrent respiratory papillomatosis associated with integrated
    human papillomavirus type 11 DNA and mutation of p53. Laryngo-scope 108(5): 735 - 740.

  20. Sedlacek T., Lindheim S., Eder C., et al.1989. Mechanism for human papillomavirus transmission at birth. Am J Obstet Gynecol 161: 55 - 59.

  21. Shinoura N., Yoshida Y, Nishimura M., Muramatsu Y, Asai A., Kirino T., Hamada H. 1999. Expresión level of Bcl-2 determines anti- or proapoptotic function. J Cancer Reser 59: 4119 - 4128.

  22. Smith E., Jhonson S., Cripe T., Pignatari S., Turek L. 1991. Perinatal vertical transmission of human papillomavirus and subsequent development of respiratory tract papillomatosis. Ann Otorhin 100: 479 -483.

  23. Soini Y., Nuorva K., Karnel D., Pollanen R., Vahakangas K., Lehto V, Paakko P. 1996. Presence of human papillomavirus DNA and abnormal p53 protein accumulation in lung cancer. Thorax 5(9): 887 - 893.

  24. Takahashi T., Nau M., Chiba I. et al. 1989. p53 a frequent targer for genetic abnormalities in lung cancer. Science 246: 491 - 494.

  25. Thomas P, De Lamballerie X., Garbe L., Castelnau O., Kleisbauer J. 1996. Detection of human papillomavirus by polymerase chain reaction in primary lung carcinoma. Bull Cancer 83(10): 842 - 846.

  26. Tormanen U., Nuorva K., Soini Y., Paakko P. 1999. Apoptotic activity is increased in parallel with the met.

Regresar
back.gif (71 bytes) Contenido

Volumenes anteriores